In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including Medicare Part D impacts from the Inflation Reduction Act, Novo Nordisk’s cuts to insulin prices, and the PBM Transparency Act of 2023.   

Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, Medicare, drug prices, PBMs 

Source Links: 

• True catastrophic coverage and shifting liability: Preparing for IRA changes 
• Inflation Reduction Act: What health plans and Part D sponsors need to know to be prepared 
• Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US 
• Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom. 
• Senate panel advances bill to reform PBMs and bring more FTC scrutiny on industry 
• Commerce Committee Approves Cantwell, Grassley Bipartisan Bill to Combat Rising Prescription Drug Prices 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector 

[email protected] 

Ryan Hummel, Executive and Head of Provider Sector 

[email protected]  

Jen Burke, Healthcare Industry Strategist 

[email protected]